Quadcap Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.49M Sell
14,265
-190
-1% -$44.3K 0.4% 61
2025
Q4
$2.99M Sell
14,455
-57
-0.4% -$11.3K 0.34% 66
2025
Q3
$2.69M Sell
14,512
-358
-2% -$61.3K 0.32% 69
2025
Q2
$2.27M Sell
14,870
-26
-0.2% -$4K 0.29% 66
2025
Q1
$2.47M Buy
14,896
+679
+5% +$106K 0.36% 59
2024
Q4
$2.06M Sell
14,217
-2,009
-12% -$311K 0.3% 68
2024
Q3
$2.63M Sell
16,226
-22
-0.1% -$3.5K 0.41% 52
2024
Q2
$2.37M Sell
16,248
-267
-2% -$39.7K 0.43% 47
2024
Q1
$2.61M Sell
16,515
-2,070
-11% -$329K 0.59% 32
2023
Q4
$2.91M Buy
+18,585
New +$2.85M 0.75% 23

Other funds holding JNJ

Quadcap Wealth Management's JNJ Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $44.3K and leaving 14,265 shares worth $3.49M. The position accounts for 0.4% of the portfolio, ranked #61.

Quadcap Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Quadcap Wealth Management held 14,265 shares of Johnson & Johnson worth $3.49M as of Q1 2026.
  • Quadcap Wealth Management sold 190 Johnson & Johnson shares in Q1 2026, an estimated $44.3K.
  • Johnson & Johnson made up 0.4% of Quadcap Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Quadcap Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.